Company research
Medicus Sciences Acquisition Corp.
CIK 1836517Updated Sep 24, 2026
Securities
MSAC price & chart
Historical security
This listing closed Feb 17, 2023. Live provider charts are shown only for current listings.
In the news
No coverage from other publishers is available.
Recent filings
Show 5 more recent filings
Financials
FY 2021 · USDSource
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2021 | FY 2020 |
|---|---|---|
| ASSETS | ||
| AssetsUSD | 93,624,429Source | 129,186Source |
| Current assets: | ||
| Cash and Cash Equivalents, at Carrying ValueUSD | 1,433,753Source | 2,000Source |
| Assets, CurrentUSD | 1,580,004Source | 2,000Source |
| LIABILITIES AND EQUITY | ||
| LiabilitiesUSD | 8,267,336Source | 110,254Source |
| Stockholders’ equity: | ||
| Additional Paid in CapitalUSD | — | 24,768Source |
| Retained Earnings (Accumulated Deficit)USD | -6,643,148Source | -6,068Source |
| Stockholders' Equity Attributable to ParentUSD | -6,642,907Source | 18,932Source |
| Liabilities and EquityUSD | 93,624,429Source | 129,186Source |
| Current liabilities: | ||
| Liabilities, CurrentUSD | 32,008Source | 110,254Source |
| Additional Financial Items | ||
| Accrued Liabilities, CurrentUSD | 32,008Source | — |
cash flow · annual statements
| Line item | FY 2021 | FY 2020 |
|---|---|---|
| Cash flows from operating activities: | ||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | 1,897,877Source | — |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -798,519Source | — |
| Cash flows from investing activities: | ||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | -92,000,000Source | — |
| Cash flows from financing activities: | ||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | 94,230,272Source | — |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | 1,431,753Source | — |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 1,433,753Source | 2,000Source |
| Additional Financial Items | ||
| Investment Income, InterestUSD | 8,585Source | — |
| Net Income (Loss) Attributable to ParentUSD | 1,897,877Source | — |
| Nonoperating Income (Expense)USD | 2,512,552Source | — |
| Operating Costs and ExpensesUSD | 614,675Source | — |
income statement · annual statements
| Line item | FY 2021 |
|---|---|
| Operating Income (Loss)USD | -614,675Source |
| Net Income (Loss) Attributable to ParentUSD | 1,897,877Source |
| Additional Financial Items | |
| Investment Income, InterestUSD | 8,585Source |
| Nonoperating Income (Expense)USD | 2,512,552Source |
| Operating Costs and ExpensesUSD | 614,675Source |